Defining Research and Care in Diabetes in Pregnancy

项目总结 第17届北美妊娠期糖尿病研究小组(DPSG-NA)会议将举行 2023年10月26-28日在伊诺瓦内科医生会议中心举行的虚拟与面对面混合会议 弗吉尼亚州福尔斯丘奇的费尔法克斯医学院。这项为期3天的研究会议聚焦于生活在 患有1型、2型和妊娠期糖尿病。DPSG-NA自25年前问世以来， 会议一直是传播数据的工具，这些数据是通过基本的、 美国和国外的翻译、临床和公共卫生研究人员和从业者。这个 会议涵盖了与妊娠期糖尿病相关的广泛问题。会议的重点是强调 重要的、及时的研究领域，以促进未来的发现。这次会议的主要目标是，而且在历史上一直是 作为讨论和新合作的推动力，开辟了探索的新领域 预防、治疗和管理方法。这些努力预计将减轻以下方面的负担 糖尿病及其对孕妇及其后代的后果。第十七次两年期会议 强烈强调多样性，强调健康和全球卫生的社会决定因素的重要性 观点，包括低收入和中等收入国家。会议目标将通过口头方式实现 演讲、圆桌讨论和辩论，将把世界各地的专家、年轻人和 对妊娠期糖尿病有明确兴趣的研究人员、学生和实习生。该计划 包括4个主题演讲，每个演讲都将献给妊娠糖尿病领域的一位巨人。这个 第一个主题演讲将由罗伯托·罗梅罗(Roberto Romero)，医学博士，理科硕士罗伯托·罗梅罗(Roberto Romero)作，以纪念奥德·兰格。罗梅罗博士会 关于产科疾病的预测和预防。此外，Cynthia Gyamfi-Bannerman医学博士， MS将在伊丽莎白·托姆纪念讲座上发表演讲，Gyamfi-Bannerman博士将在演讲中谈到托姆博士的 作为MFMU网络的生物统计学家，在改变糖尿病的临床护理方面做出了贡献。最后，凯文 Herold，医学博士将在Lois Jovanovic纪念演讲中发言，并将讨论减少糖尿病的策略 在美国流行。其他发言者包括知名专家和年轻的调查人员，约有 分配给演讲者-与会者讨论的会议时间的20%。年轻的调查员演讲是一种 会议的重要方面，它们是帮助将新一代科学家带入 我们的社区，培养他们的成熟。与会者之间的非正式讨论是这一独特的 会议促进合作、多方面的方法来改善孕妇的健康和福祉 患有糖尿病的妇女及其后代。

PROJECT SUMMARY The 17th biennial meeting of the Diabetes in Pregnancy Study Group of North America (DPSG-NA) will be held on October 26-28, 2023 as a hybrid virtual and in-person meeting at the Physicians Conference Center at Inova Fairfax Medical Campus in Falls Church, VA. This 3-day research meeting focuses on pregnant individuals living with type 1, type 2, and gestational diabetes mellitus. Since its inception over 25 years ago, the DPSG-NA meetings have been a vehicle for the dissemination of data, gathered through collaboration among basic, translational, clinical, and public health researchers and practitioners both in the United States and abroad. The meeting covers a broad range of issues related to diabetes in pregnancy. The focus of the meeting is to highlight major, timely research areas to catalyze future discovery. The major goal of this meeting is, and has historically been, to serve as a driving force for discussions and new collaborations that open novel areas of exploration into prevention, treatment, and management approaches. These efforts are expected to reduce the burden of diabetes disease and its consequences for pregnant individuals and their offspring. The 17h biennial meeting has a strong emphasis on diversity, emphasizing the importance of social determinants of health and global perspectives, including low-and-middle-income countries. The meeting goals will be achieved through oral presentations, roundtable discussions, and debates that will bring together the world’s experts, young investigators, students, and trainees who have a committed interest to diabetes in pregnancy. The program includes 4 keynote addresses that each will be dedicated to a giant in the field of diabetes in pregnancy. The first keynote will be given in memory of Oded Langer by Roberto Romero, MD, DMed, Sci. Dr. Romero will speak on the prediction and prevention of obstetrical diseases. In addition, Cynthia Gyamfi-Bannerman, MD, MS will give the Elizabeth Thom Memorial Lecture where Dr. Gyamfi-Bannerman will speak of Dr. Thom’s contribution as the biostatistician of the MFMU network in changing clinical care in diabetes. Finally, Kevan Herold, MD will speak in the Lois Jovanovic Memorial Lecture and will address strategies to reduce the diabetes epidemic in the United States. Other speakers include established experts and young investigators, with about 20% of the meeting time allocated for speaker-conferee discussions. Young investigator presentations are an important aspect of the meeting, and they are an effective tool to help bring a new generation of scientists into our community and foster their maturation. Informal discussions among conferees are highlights of this unique meeting that fosters a collaborative, multifaceted approach to improving the health and wellbeing of pregnant women with diabetes and their offspring.